IDO-IN-12
IDO-IN-12 is an indoleamine 2,3-dioxygenase (IDO) inhibitor extracted from patent WO 2017181849 A1.
Product Specifications
CAS Number
[1888341-29-4]
Product Name Alternative
SB-262470A,Mutagenic Impurity of Tenofovir Disoproxil; Tenofovir Impurity 2,Methyl (2E,4E,6Z)-decatrienoate
UNSPSC
12352005
Target
Indoleamine 2,3-Dioxygenase (IDO)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/IDO-IN-12.html
Concentration
10mM
Purity
99.22
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
FC1=CC=C(N2C(C3=NON=C3NCCSC)=NOC2=O)C=C1Br
Molecular Formula
C13H11BrFN5O3S
Molecular Weight
416.23
References & Citations
[1]Shenghua Wu, et al. Indoleamine 2,3-dioxygenase inhibitor, preparation method therefor, and application. WO 2017181849 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Human recombinant CXCL3 (C-X-C motif chemokine 3) protein, AF
FGFR4 (Fibroblast Growth Factor Receptor 4, FGFR-4, CD334 Antigen, FGFR4, JTK2, TKF) (PE)
FGFR4 (Fibroblast Growth Factor Receptor 4, FGFR-4, CD334 Antigen, FGFR4, JTK2, TKF) (PE)